Three imidazo[1,2-a]pyridine-3-nitrosated (L-1, L-2, L-3) and a 3-formyl imidazo[1,2-a]-pyridine thiosemicarbazone (L-4) were synthesized and evaluated for their effects in the elevated plus maze, burying behavior test, rotarod performance, the horizontal wire test, and locomotor activity. L-2 and L-3 increased the percent time spent in the open arms of the plus maze at doses of 1 and 2 mg/kg without modifying the number of total entries. In addition, L-2 and L-3 (1 mg/kg) increased the number of open arm entries indicating anxiolytic-like activity at this dose. In the burying behavioral test, L-1 (2-8 mg/kg), L-2 (8 mg/kg), and L-3 (4 and 8 mg/kg), induced a clear reduction in cumulative burying behavior, without modifying burying behavior latency, thus reducing experimental anxiety. In the rotarod test, L-1 and L-2 impaired rotarod performance only at the highest evaluated dose (64 mg/kg) at which reduction of motor activity was observed and thereby no conclusions about myorelaxant effects can be proposed. All compounds showed a clear sedative effect and corresponding ED 50 values were obtained. Results indicate that compounds L-1, L-2, and L-3 show a sedative and an anxiolytic profile. Drug Dev Res 71:371-381, 2010.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.